0
Letters |

Elective Intra-aortic Balloon Pump Placement in High-Risk Percutaneous Coronary Intervention

Gen-Min Lin, MD; Kai-Min Chu, MD, PhD; Chih-Lu Han, MD, PhD
JAMA. 2010;304(20):2240-2242. doi:10.1001/jama.2010.1697
Text Size: A A A
Published online

To the Editor: In their randomized controlled trial comparing elective intra-aortic balloon pump (IABP) counterpulsation vs no planned IABP support in high-risk percutaneous coronary intervention (PCI), Dr Perera and colleagues1 concluded that elective IABP did not reduce the incidence of major adverse cardiac and cardiovascular events (MACCE). We agree with the study design, which used composite end points analyzed over a short period, because most patients enrolled in the Balloon Pump–Assisted Coronary Intervention Study (BCIS-1) had severely impaired left ventricular systolic function and ischemic heart failure, which conferred a high risk of death within 5 years that would probably blunt any beneficial effect of IABP intervention at long-term follow-up.2 3

Although the authors reached conclusions about negative results in BCIS-1, we have 2 concerns that may contradict this. First, differences in the low incidence rates of cerebrovascular accidents and further revascularization in the primary end points and mortality in the secondary end points might have been statistically significant if the sample size were larger. Although overall associated benefits and hazards were in balance, the sample size effect on mortality should be emphasized because reduction of death rate during high-risk PCI is the major goal of prophylactic IABP insertion for the BCIS-1 cohort.

Second, a confidence bias for the procedure may have existed between these 2 groups, with the physician possibly spending more time dealing with higher-risk coronary lesions in the group undergoing prophylactic IABP insertion, including left main artery disease and left anterior descending coronary artery ostial stenosis, which could have resulted in increased risk of death.4 5 Accordingly, the authors should not only describe the severity scores of the coronary anatomy but also compare the procedure time and which target coronary vessels underwent PCI between groups.

AUTHOR INFORMATION

Financial Disclosures: None reported.

REFERENCES

Perera D, Stables R, Thomas M,  et al; BCIS-1 Investigators.  Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial.  JAMA. 2010;304(8):867-874
PubMed
Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects.  Circulation. 1993;88(1):107-115
PubMed
McMurray JJ, Kjekshus J, Gullestad L,  et al; CORONA Study Group.  Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.  Circulation. 2009;120(22):2188-2196
PubMed
Califf RM, Phillips HR III, Hindman MC,  et al.  Prognostic value of a coronary artery jeopardy score.  J Am Coll Cardiol. 1985;5(5):1055-1063
PubMed
Chieffo A, Stankovic G, Bonizzoni E,  et al.  Early and mid-term results of drug-eluting stent implantation in unprotected left main.  Circulation. 2005;111(6):791-795
PubMed

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Perera D, Stables R, Thomas M,  et al; BCIS-1 Investigators.  Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial.  JAMA. 2010;304(8):867-874
PubMed
Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study subjects.  Circulation. 1993;88(1):107-115
PubMed
McMurray JJ, Kjekshus J, Gullestad L,  et al; CORONA Study Group.  Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.  Circulation. 2009;120(22):2188-2196
PubMed
Califf RM, Phillips HR III, Hindman MC,  et al.  Prognostic value of a coronary artery jeopardy score.  J Am Coll Cardiol. 1985;5(5):1055-1063
PubMed
Chieffo A, Stankovic G, Bonizzoni E,  et al.  Early and mid-term results of drug-eluting stent implantation in unprotected left main.  Circulation. 2005;111(6):791-795
PubMed
November 24, 2010
Divaka Perera, MD, MRCP; Rodney Stables, DM, FRCP; Simon Redwood, MD, FRCP
JAMA. 2010;304(20):2240-2242.
November 24, 2010
Gábor Tamás Szabó, MD; Ildikó Rácz, MD; Zsolt Koszegi, MD, PhD
JAMA. 2010;304(20):2240-2242.
November 24, 2010
Annemarie E. Engström, MD; Krischan D. Sjauw, MD; José P. S. Henriques, MD, PhD
JAMA. 2010;304(20):2240-2242.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.